These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8960436)

  • 1. Sustained improvement of pulmonary haemodynamics with low-dose of nifedipine in primary pulmonary hypertension.
    Shimabukuro M; Chibana T; Yoshida H; Nagamine F; Takasu N
    Eur Heart J; 1996 Dec; 17(12):1911-2. PubMed ID: 8960436
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S; Schrader BJ; Kaufmann E; Vestal RE; Rich S
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Corrective effect of nitrates and calcium antagonists on hemodynamics and ventilation in chronic bronchitis patients with a syndrome of pulmonary hypertension].
    Sil'vestrov VP; Surovov IuA; Semin SN; Pakulin IA; Larin NV
    Ter Arkh; 1987; 59(3):100-5. PubMed ID: 3110989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of calcium channel antagonists in primary pulmonary hypertension in association with human immunodeficiency virus infection].
    Bragulat E; García F; Fernández F; Ballester E; Villalta J; Grau JM
    An Med Interna; 1998 Feb; 15(2):114. PubMed ID: 9542214
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial comparing the effects of a low-dose combination of nifedipine GITS and valsartan versus high-dose monotherapy on central hemodynamics in patients with inadequately controlled hypertension: FOCUS study.
    Park JB; Ha JW; Jung HO; Rhee MY;
    Blood Press Monit; 2014 Oct; 19(5):294-301. PubMed ID: 24915052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival--a question of active treatment. High-dose calcium blockers in pulmonary hypertension].
    Husebye ES; Wibell L
    Lakartidningen; 1994 Jun; 91(26-27):2573-5. PubMed ID: 8046974
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term treatment with a new calcium antagonist, felodipine, in chronic obstructive lung disease.
    Bratel T; Hedenstierna G; Nyquist O; Ripe E
    Eur J Respir Dis; 1986 May; 68(5):351-61. PubMed ID: 3732430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension.
    Archer SL; Yankovich RD; Chesler E; Weir EK
    J Pharmacol Exp Ther; 1985 Apr; 233(1):12-7. PubMed ID: 3872360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary pulmonary hypertension: effects of nifedipine.
    Camerini F; Alberti E; Klugmann S; Salvi A
    Br Heart J; 1980 Sep; 44(3):352-6. PubMed ID: 7426194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine in acute coronary syndromes: Furberg's refrain revisited.
    Rafflenbeul W
    Eur Heart J; 1996 Aug; 17(8):1147-52. PubMed ID: 8869854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and tolerability of two forms of nifedipine in the treatment of hypertension].
    Mukhin NA; Fomina IG; Kozlovskaia LV; Bragina AE; Fomin VV
    Kardiologiia; 2005; 45(4):44-8. PubMed ID: 15940191
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination of nifedipine and diltiazem in refractory coronary spasm. Evaluation by provocation tests].
    Malpartida F; de la Morena G; Barba J; Ancín R; Azpilicueta J; Querejeta R
    Rev Esp Cardiol; 1985; 38(3):170-6. PubMed ID: 4040261
    [No Abstract]   [Full Text] [Related]  

  • 14. [Calcium channel blockers in the treatment of primary open-angle glaucoma].
    Pozniak NI; Kovshel' NM; Grigorovich IL; Belova AV; Vlasov SF
    Vestn Oftalmol; 1998; 114(3):5-6. PubMed ID: 9720386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease.
    Bratel T; Hedenstierna G; Nyquist O; Ripe E
    Eur J Respir Dis; 1985 Oct; 67(4):244-53. PubMed ID: 4076363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term use of the calcium antagonist nifedipine (corinfar) in the treatment of patients with primary pulmonary hypertension].
    Khosseĭn A; Mukharliamov NM; Mareev VIu; Lobova NM; Ageev FT
    Kardiologiia; 1988 Apr; 28(4):54-8. PubMed ID: 3292811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension: predictive ability and consequences on haemodynamics and gas exchange.
    Jolliet P; Bulpa P; Thorens JB; Ritz M; Chevrolet JC
    Thorax; 1997 Apr; 52(4):369-72. PubMed ID: 9196521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of the use of prolonged nifedipine in patients with arterial hypertension and chronic obstructive lung disease].
    Statsenko ME; Piliasova OV; Paravaeva VP
    Kardiologiia; 2008; 48(4):34-7. PubMed ID: 18447838
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic evaluation of nifedipine in primary pulmonary hypertension--short and long term effects].
    Yamaguchi S; Tsuiki K; Hayasaka M; Oguma M; Ohta I; Kaminishi T; Sukekawa H; Kanaya T; Yasui S
    Kokyu To Junkan; 1986 Feb; 34(2):171-6. PubMed ID: 3704359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pulmonary arterial hypertension treated with prostacyclin or calcium blockers].
    Andreassen AK; Geiran O; Madsen S; Hognestad A; Simonsen S
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3393-6. PubMed ID: 14713978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.